ATTN LogoMenu
4EXASTier 7

EXACT SCIENCES CORP 4

0001193125-26-118745

View on SEC EDGAR

Director Kimberly J. Popovits had 6,725 shares of Exact Sciences common stock cashed out for $105.00 per share in a merger-related disposition, leaving her with no remaining shares.

On March 23, 2026, director Kimberly J. Popovits disposed of all her shares of Exact Sciences Corporation common stock in connection with the closing of the company’s merger with Abbott Laboratories. Under the merger agreement, each share of Exact Sciences common stock, including any shares subject to vesting or other restrictions, was fully vested (if applicable), canceled, and converted into the right to receive $105.00 in cash. Popovits’ 6,725 shares of common stock reported as beneficially owned immediately prior to the effective time were exchanged for cash consideration of approximately $706,125, resulting in her post-transaction direct ownership of Exact Sciences common stock being reduced to zero, as the issuer became a wholly owned subsidiary of Abbott.

Filing Facts

CIK
1124140
Ticker
EXAS
Form
4
Source Type
sec
Accession
0001193125-26-118745
Alert Tier
7
EXACT SCIENCES CORP 4 | ATTN